343 related articles for article (PubMed ID: 34026653)
1. Current State of Personalized Genitourinary Cancer Radiotherapy in the Era of Precision Medicine.
Kamran SC; Efstathiou JA
Front Oncol; 2021; 11():675311. PubMed ID: 34026653
[TBL] [Abstract][Full Text] [Related]
2. Applying Precision Oncology Principles in Radiation Oncology.
Kamran SC; Mouw KW
JCO Precis Oncol; 2018; 2():. PubMed ID: 32914000
[TBL] [Abstract][Full Text] [Related]
3. Primary Results of Patients with Genitourinary Malignancies Presented at a Molecular Tumor Board.
Michaelis J; Himmelsbach R; Metzger P; Lassmann S; Börries M; Werner M; Miething C; Höfflin R; Illert AL; Duyster J; Becker H; Sigle A; Gratzke C; Grabbert M
Urol Int; 2024 Apr; ():1-9. PubMed ID: 38626735
[TBL] [Abstract][Full Text] [Related]
4. Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.
Matta R; Chapple CR; Fisch M; Heidenreich A; Herschorn S; Kodama RT; Koontz BF; Murphy DG; Nguyen PL; Nam RK
Eur Urol; 2019 Mar; 75(3):464-476. PubMed ID: 30573316
[TBL] [Abstract][Full Text] [Related]
5. Biorepositories and Databanks for the Development of Novel Biomarkers for Genitourinary Cancer Prevention and Management.
Wagner H; Kenk M; Fraser M; Berlin A; Fleshner N
Eur Urol Focus; 2021 May; 7(3):513-521. PubMed ID: 34167926
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiation therapy (SBRT) for genitourinary malignancies.
Teh BS; Ishiyama H; Mathews T; Xu B; Butler EB; Mayr NA; Lo SS; Lu JJ; Blanco AI; Paulino AC; Timmerman RD
Discov Med; 2010 Sep; 10(52):255-62. PubMed ID: 20875347
[TBL] [Abstract][Full Text] [Related]
7. Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine.
Dulaney CR; Osula DO; Yang ES; Rais-Bahrami S
Prostate Cancer; 2016; 2016():4897515. PubMed ID: 27022486
[TBL] [Abstract][Full Text] [Related]
8. Present and future of personalized medicine in adult genitourinary tumors.
Ciccarese C; Santoni M; Massari F; Cheng L; Lopez-Beltran A; Scarpelli M; Conti A; Tortora G; Cascinu S; Montironi R
Future Oncol; 2015; 11(9):1381-8. PubMed ID: 25952784
[TBL] [Abstract][Full Text] [Related]
9. Precision Oncology and Genomically Guided Radiation Therapy: A Report From the American Society for Radiation Oncology/American Association of Physicists in Medicine/National Cancer Institute Precision Medicine Conference.
Hall WA; Bergom C; Thompson RF; Baschnagel AM; Vijayakumar S; Willers H; Li XA; Schultz CJ; Wilson GD; West CML; Capala J; Coleman CN; Torres-Roca JF; Weidhaas J; Feng FY
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):274-284. PubMed ID: 28964588
[TBL] [Abstract][Full Text] [Related]
10. Circulating Tumor Cells in Genitourinary Malignancies: An Evolving Path to Precision Medicine.
Hugen CM; Zainfeld DE; Goldkorn A
Front Oncol; 2017; 7():6. PubMed ID: 28191452
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy Combined With Radiation Therapy for Genitourinary Malignancies.
Ukleja J; Kusaka E; Miyamoto DT
Front Oncol; 2021; 11():663852. PubMed ID: 34041029
[TBL] [Abstract][Full Text] [Related]
12. Targeted Therapy and Personalized Medicine.
Saeed RF; Awan UA; Saeed S; Mumtaz S; Akhtar N; Aslam S
Cancer Treat Res; 2023; 185():177-205. PubMed ID: 37306910
[TBL] [Abstract][Full Text] [Related]
13. How Advances in Imaging Will Affect Precision Radiation Oncology.
Jaffray DA; Das S; Jacobs PM; Jeraj R; Lambin P
Int J Radiat Oncol Biol Phys; 2018 Jun; 101(2):292-298. PubMed ID: 29726358
[TBL] [Abstract][Full Text] [Related]
14. Modeling Precision Cardio-Oncology: Using Human-Induced Pluripotent Stem Cells for Risk Stratification and Prevention.
Perry TR; Roberts ML; Sunkara B; Maddula R; McLeish T; Gomez J; Lucas J; Rayan D; Patel S; Liang M; Bosnjak ZJ; Brown SA
Curr Oncol Rep; 2021 May; 23(7):77. PubMed ID: 33937943
[TBL] [Abstract][Full Text] [Related]
15. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
16. Immune checkpoint inhibitors in genitourinary malignancies.
Thana M; Wood L
Curr Oncol; 2020 Apr; 27(Suppl 2):S69-S77. PubMed ID: 32368176
[TBL] [Abstract][Full Text] [Related]
17. Current Status and Challenges in Rare Genitourinary Cancer Research and Future Directions.
Cigliola A; Prakash G; Li R; Oualla K; Shilpa G; Kamat AM; Chahoud J; Necchi A; Spiess PE
Curr Oncol Rep; 2024 Jun; ():. PubMed ID: 38847974
[TBL] [Abstract][Full Text] [Related]
18. Omics sciences and precision medicine in glioblastoma.
Micheletti C; Bonetti G; Madeo G; Gadler M; Benedetti S; Guerri G; Cristofoli F; Generali D; Donofrio CA; Cominetti M; Fioravanti A; Riccio L; Manganotti P; Caruso P; Bernini A; Fulcheri E; Stuppia L; Gatta V; Cecchin S; Marceddu G; Bertelli M
Clin Ter; 2023; 174(Suppl 2(6)):77-84. PubMed ID: 37994751
[TBL] [Abstract][Full Text] [Related]
19. Molecular diagnostics tailoring personalized cancer therapy-an oncologist's view.
Riedl JM; Moik F; Esterl T; Kostmann SM; Gerger A; Jost PJ
Virchows Arch; 2024 Feb; 484(2):169-179. PubMed ID: 37982847
[TBL] [Abstract][Full Text] [Related]
20. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
